WAY-381628|CAS 79201-40-4|DC Chemicals

Cas No.:	79201-40-4
Chemical Name:	WAY-381628
Synonyms:	WAY381628;WAY 381628;Hydrazinecarboxylic acid, cycloheptylidene-, 1,1-dimethylethyl ester;Hydrazinecarboxylic acid, 2-cycloheptylidene-, 1,1-dimethylethyl ester;WAY-381628;SR-01000032310;AKOS034408699;SR-01000032310-1;Z49621227;G89895;79201-40-4;DTXSID601236573;tert-Butyl 2-cycloheptylidenehydrazine-1-carboxylate;1,1-Dimethylethyl 2-cycloheptylidenehydrazinecarboxylate;AC-37785;(E)-N-cycloheptylidene(tert-butoxy)carbohydrazonic acid;AS-88050
SMILES:	O(C(N/N=C1\CCCCCC\1)=O)C(C)(C)C
Formula:	C₁₂H₂₂N₂O₂
M.Wt:	226.32
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC67845	N-Me-Thalidomide 4-fluoride	N-Me-Thalidomide 4-fluoride is a ligand for E3 ligase, used for the synthesis of Anti-inflammatory agent 70 .
DC67844	CRBN ligand-880	CRBN ligand-880 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein. CRBN ligand-880 can be linked to a target protein ligand via a linker to form a PROTAC.
DC67843	6-hydroxy-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid
DC67842	Tert-butyl 4-(4-aMino-3-Methoxyphenyl)piperazine-1-carboxylate
DC67841	Boc-NH-PEG4	Boc-NH-PEG4 (PROTAC Linker 12) is a PEG-based PROTAC linker can be used in the synthesis of PROTACs.
DC67840	tert-Butyl (6-hydroxyhexyl)carbamate	tert-Butyl (6-hydroxyhexyl)carbamate is a PROTAC linker that can be used in the synthesis of PROTACs.
DC67839	tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate (Standard)	tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate (Standard) is the analytical standard of tert-Butyl N-(2,6-dioxopiperidin-3-yl)carbamate. This product is intended for research and analytical applications.
DC67838	3-amino-1-methylpiperidine-2,6-dione hydrochloride
DC67837	(S)-3-Amino-piperidine-2,6-dione hydrochloride
DC67836	(R)-3-Aminopyrrolidine-2,5-dione	(R)-3-Aminopyrrolidine-2,5-dione is a potential anticonvulsant agent and its derivatives have comparable in vivo efficacy.